tiprankstipranks
Trending News
More News >
Dogwood Therapeutics (DWTX)
NASDAQ:DWTX
US Market

Dogwood Therapeutics (DWTX) Financial Statements

Compare
257 Followers

Dogwood Therapeutics Financial Overview

Dogwood Therapeutics's market cap is currently $89.19M. The company's EPS TTM is $-8.2; its P/E ratio is -0.11; Dogwood Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -12.18K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -12.23M$ -5.45M$ -12.32M$ -15.64M$ -10.01M
EBITDA$ -12.25M$ -5.45M$ -12.32M$ -15.64M$ -10.01M
Net Income$ -12.35M$ -5.30M$ -12.25M$ -15.96M$ -10.35M
Balance Sheet
Cash & Short-Term Investments$ 14.85M$ 3.32M$ 7.03M$ 14.01M$ 29.80M
Total Assets$ 94.31M$ 4.17M$ 8.37M$ 15.78M$ 31.47M
Total Debt$ 15.59M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 737.71K$ -3.32M$ -7.03M$ -14.01M$ -29.80M
Total Liabilities$ 30.03M$ 358.55K$ 1.04M$ 1.28M$ 1.53M
Stockholders' Equity$ 64.28M$ 3.81M$ 7.33M$ 14.50M$ 29.94M
Cash Flow
Free Cash Flow$ -8.79M$ -4.87M$ -11.47M$ -15.69M$ -3.90M
Operating Cash Flow$ -8.79M$ -4.87M$ -11.47M$ -15.69M$ -3.90M
Investing Cash Flow$ 3.76M$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 16.70M$ 1.16M$ 4.49M$ -97.60K$ 33.38M
Currency in USD

Dogwood Therapeutics Earnings and Revenue History

Dogwood Therapeutics Debt to Assets

Dogwood Therapeutics Cash Flow

Dogwood Therapeutics Forecast EPS vs Actual EPS